Nicholas Levine, MD in Moscow, ID - Medicare

Nicholas Levine, MD is a medicare enrolled "Neurological Surgery" physician in Moscow, Idaho. His current practice location is 803 S Main St Ste 320, Moscow, Idaho. You can reach out to his office (for appointments etc.) via phone at (208) 883-1008.

Nicholas Levine is licensed to practice in Idaho (license number M-17459) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1023229325.

Contact Information

	Nicholas Levine, MD
	803 S Main St Ste 320, Moscow, ID 83843-2695
	(208) 883-1008
	(208) 883-4563

Physician's Profile

Full Name	Nicholas Levine
Gender	Male
Speciality
Experience	Years
Location	803 S Main St Ste 320, Moscow, Idaho
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Nicholas Levine attended and graduated from in

NPI Data:

NPI Number: 1023229325
Provider Enumeration Date: 05/25/2007
Last Update Date: 12/12/2023

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Nicholas Levine such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023229325	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207T00000X	Neurological Surgery	C143668 (California)	Secondary
207T00000X	Neurological Surgery	M-17459 (Idaho)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nicholas Levine is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Nicholas Levine, MD 803 S Main St Ste 320, Moscow, ID 83843-2695 Ph: (208) 883-1008	Nicholas Levine, MD 803 S Main St Ste 320, Moscow, ID 83843-2695 Ph: (208) 883-1008

News Archive

New book focuses on life events resulting in teen motherhood

If Diane could reverse time, she never would have slammed the door-an act of teen frustration and ongoing family conflict that finally got her kicked out of her mother's house.

Normal Htt protein regulates formation of cellular structures in mouse model of HD

Huntington disease is a devastating neurogenerative disorder that causes a progressive loss of functional capacity and reduced life span. It is an inherited condition caused by a mutant HTT gene. Although this has been known for many years, the functions of the normal Htt protein and the mechanisms by which the mutant protein generated from the mutant HTT gene causes disease are not well understood.

Talazoparib did not show overall survival benefit in patients with advanced BRCA-mutated breast cancer

New data from the Phase III EMBRACA trial led by researchers at The University of Texas MD Anderson Cancer Center found the PARP inhibitor talazoparib did not demonstrate a statistically significant overall survival (OS) benefit for patients with metastatic HER2-negative breast cancer and mutations in the BRCA1/2 genes.

New report on overview of medical researchers' training across Europe

Fostering and improving medical research education is crucial to biomedical research and clinical patient treatment, and as such it has been identified as the main challenge in every joint European Science Foundation (ESF) - European Research Medical Councils (EMRC) strategy report. A new policy report entitled "Medical Research Education in Europe" has just been published looking at crucial factors to improve medical research education throughout Europe.

Access to dermatologist improves melanoma-related health outcomes

Individuals whose melanoma is diagnosed by a dermatologist may be more likely to have early-stage cancer and to survive five years than those with melanoma diagnosed by a non-dermatologist, according to a report in the April issue of Archives of Dermatology.

Nicholas Levine, MD - Medicare in Moscow, ID